News and Trends 23 Nov 2022 Significant therapeutic potential of OSE Immunotherapeutics’ CLEC-1 published …this journal with the highest scientific standards. Our teams worked closely on CLEC-1 target and identified for the first time TRIM-21 as an endogenous ligand induced during cell stress and/or… November 23, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 31 Oct 2025 Spooky science: lab-grown breakthroughs or nightmares? …back. The pushback doesn’t seem to faze Colossal as they plan on reviving the woolly mammoth by 2028, as well as other extinct species like the moa bird and the Tasmanian tiger. And last month, it announced that it… October 31, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Startup Scout 7 Jun 2019 This Biotech Transplants Cells into the Eye to Personalize Diabetes Treatments …James Hall, told me. To personalize a treatment, it’s important to visualize the tissue that you are targeting. Since it is not easy to image cells in the pancreas, Biocrine’s… June 7, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2023 First patient enrolled in Pharming APSD trial …at UCLA, said: “In treating APDS, the current standard of care is to use an array of supportive therapies. While these therapies can treat some of the manifestations of APDS,… February 21, 2023 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 Mar 2023 Research looks to make drug appear like brain tumor ‘food’ …the energy production in the cells but also triggers other processes that result in what is called, Apoptosis, (self-killing) in the cells. And now we know that brain tumors have… March 8, 2023 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 25 Sep 2023 Base editing hits the clinic in the U.S. …bone marrow transplant – that the doctors turned to T cell therapy – but with a twist. The DNA in the T cells were modified with the help of base… September 25, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Oct 2023 How close are we to a cure for metastatic breast cancer? …identify a way to treat the area surrounding breast tumors that have spread to the bone so that the tumors become vulnerable to attack by the immune system. The researchers… October 13, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2017 It’s World Diabetes Day! But What is Biotech Doing to Fight the Disease? …has developed Imotopes, peptides that stimulate CD4+ T cells to kill immune cells that are attacking the pancreas, to cure type 1 diabetes. It has started a Phase I clinical… November 14, 2017 - 4 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jun 2021 Scotland’s Top 10 Biotech Companies to Watch Out For …T cells. These cells target solid tumors more easily and more safely than alpha beta T cells — the most common raw materials in CAR-T. Additionally, the company aims to… June 30, 2021 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies …anti-cancer therapies that can modulate the TME in immune-excluded tumors through our proprietary approach that utilizes biomarkers to match our therapeutic approaches to individual patients based on the specific characteristics… November 10, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 11 Jun 2025 Can gene therapy treat vision loss? …the treatment. In addition, the cells of the retina can keep this DNA functioning for longer than other cells in the body. This means that a single dose injected into… June 11, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2023 10 biotech companies leading innovation in the Asia-Pacific region …Conjugation (ACC) platform. ACC is a tumor-targeting technology that links antibodies directly to gamma-delta T cells and natural killer (NK) cells in order to enhance their tumor killing ability without… November 14, 2023 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email